JAG Capital Management
Our archive holds 9 letters from JAG Capital Management, behind 4 investment theses and positions in 66 companies. Every quote below is copied verbatim from the letter it came from.
Get an email when this fund publishes its next letter
5 strategies
JAG Capital Management publishes a letter per strategy. Each one has its own page — what it holds, what it bought, what it wrote.
- JAG Capital Management Large Cap Growth Portfolio2
22 companies
YTD +15.6% · 1Y +18.1% · 3Y +26.7%/yr (Sep 30, 2026)
- JAG Capital Management Small Mid Cap Growth Strategy2
46 companies
YTD +47.0% · 1Y +57.9% · 3Y +29.2%/yr (Jun 30, 2026)
- JAG Capital Management Corporate Fixed Income1
6 companies
YTD +0.2% · 1Y +3.0% · 3Y +4.9%/yr (Jun 30, 2026)
- JAG Capital Management Enhanced Core Fixed Income1
6 companies
YTD +0.1% · 1Y +2.5% · 3Y +4.4%/yr (Jun 30, 2026)
- JAG Capital Management Quarterly Comments1
2 companies
Returns as reported in each strategy’s latest letter, extracted automatically and not verified by us; one share class, in its own currency. Not investment advice. Past performance does not predict future returns.
Also filed under JAG Capital Management.
What they bought and sold · 52 moves
- New positionOscar HealthSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - ExitedC.H. RobinsonSeptember 2026
“C.H. Robinson (CHRW) is one of the largest third-party logistics providers in North America. We exited our position following an adverse advisory verdict from a Texas jury in a negligent hiring case that resulted in the death of three people.”
Read the letter - TrimmedON SemiconductorSeptember 2026
“ON Semiconductor (ON) is one of the leading industrial and auto chip makers. We divested our position as recent large acquisition news weighed on investor sentiment and relative strength continued to deteriorate.”
Read the letter - ExitedIntelSeptember 2026
“We divested our position following significant outperformance as the upside potential is limited due to elevated expectations, in our view.”
Read the letter - TrimmedElanco Animal HealthSeptember 2026
“Elanco Animal Health (ELAN) is an animal health company. We divested our position as relative strength deteriorated tied to industry-wide demand concerns and fears of rising competition.”
Read the letter - ExitedXPOSeptember 2026
“We divested our position given deteriorating relative strength and mounting macro headwinds, including higher interest rate yields and elevated fuel costs.”
Read the letter - TrimmedApplied MaterialsSeptember 2026
“We divested our position as relative strength continued to deteriorate after the company missed its quarterly earnings expectations.”
Read the letter - ExitedWalmartSeptember 2026
“We liquidated our position after the company delivered weaker-than- expected forward guidance in their most recent earnings report, which makes us less confident in the short/intermediate term outlook for the shares.”
Read the letter - New positionElasticSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - New positionManchester UnitedSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - ExitedRegal RexnordSeptember 2026
“Regal Rexnord (RRX) manufactures motors and power transmission components used in a wide variety of industrial applications. We exited our position as relative strength continued to deteriorate following a revenue and margin miss.”
Read the letter - New positionMatch GroupSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - New positionFormFactorSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - ExitedBloom EnergySeptember 2026
“We exited our position as relative strength continued to deteriorate and as the company could face challenges in scaling production given limitations on the supply of scandium.”
Read the letter - ExitedAstera LabsSeptember 2026
“We divested our position as relative strength continued to deteriorate after the company missed its quarterly earnings expectations.”
Read the letter - ExitedBlue BirdSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - New positionPalantirSeptember 2026
“We are re-establishing the position as US commercial revenue growth continues to accelerate as enterprises adopt the company’s industry-leading AI solutions.”
Read the letter - New positionRubrikSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - New positionSterling InfrastructureSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - New positionAbivaxSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - TrimmedXPOSeptember 2026
“XPO (XPO) is a leading less-than-truckload (LTL) trucking firm. We divested our position given deteriorating relative strength and mounting macro headwinds, including higher yields and elevated fuel costs.”
Read the letter - New positionLyftSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - TrimmedMasTecSeptember 2026
“MasTec (MTZ) is an infrastructure construction company. We divested our position as valuations became very demanding after a significant outperformance during the holding period.”
Read the letter - New positionCytokineticsSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - ExitedAtmus FiltrationSeptember 2026
“Atmus Filtration (ATMU) manufactures filters for trucks and industrial equipment. We exited our position as the relative strength continued to deteriorate following a revenue miss against elevated expectations.”
Read the letter - New positionNordson CorporationSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - New positionAtlassianSeptember 2026
“Recent earnings showed growth acceleration across key metrics as Atlassian’s AI offerings are gaining traction.”
Read the letter - New positionVisaSeptember 2026
“We believe the stock is well positioned to outperform tied to healthy consumer demand and undemanding valuations.”
Read the letter - New positionSphere EntertainmentSeptember 2026
Listed in JAG Capital Management’s reported holdings.
Read the letter - AddedVeradermicsJune 2026
“Veradermics (MANE) is a biotech company working on developing a new and improved treatment for Pattern Hair Loss (commonly referred to as Male Pattern”
Read the letter
Showing the 30 most recent of 52 recorded moves.
Companies held · 66
Every company JAG Capital Management has disclosed a position in across our archive, with the letter that last mentioned it.
- AbivaxSep 2026
- Advanced Micro DevicesJun 2026
- Akamai TechnologiesJun 2026
- AllientJun 2026
- AlphabetJun 2026
- Amazon.com IncJun 2026
- AppleSep 2026
- Applied MaterialsSep 2026
- Arrow Electronics IncJun 2026
- Astera LabsSep 2026
- AtlassianSep 2026
- Atmos Energy CorporationJun 2026
- Atmus FiltrationSep 2026
- Block, Inc.Jun 2026
- Bloom EnergySep 2026
- Blue BirdSep 2026
- BrinkerJun 2026
- C.H. RobinsonSep 2026
- Carpenter TechnologySep 2026
- Casey’s General StoresSep 2026
- CienaJun 2026
- Coca-Cola ConsolidatedJun 2026
- CytokineticsSep 2026
- D.R. Horton IncJun 2026
- DellJun 2026
- DuolingoJun 2026
- Elanco Animal HealthSep 2026
- ElasticSep 2026
- Ensign GroupJun 2026
- FactSet Research SystemsJun 2026
- FastlyJun 2026
- FormFactorSep 2026
- Green Brick PartnersJun 2026
- Guardant HealthSep 2026
- IntelSep 2026
- JabilJun 2026
- Jazz PharmaceuticalJun 2026
- LyftSep 2026
- Manchester UnitedSep 2026
- MasTecSep 2026
- Match GroupSep 2026
- MetaSep 2026
- MicronJun 2026
- MicrosoftSep 2026
- NateraSep 2026
- Nordson CorporationSep 2026
- NovaSep 2026
- ON SemiconductorSep 2026
- OracleJun 2026
- Oscar HealthSep 2026
- PalantirSep 2026
- PhotronicsJun 2026
- Regal RexnordSep 2026
- RepligenJun 2026
- RubrikSep 2026
- SharkNinjaJun 2026
- Space ExpJun 2026
- Sphere EntertainmentSep 2026
- Sterling InfrastructureSep 2026
- TKO GroupJun 2026
- VeradermicsJun 2026
- VertivSep 2026
- VicorJun 2026
- VisaSep 2026
- WalmartSep 2026
- XPOSep 2026
Theses · 4
- September 2026
Manchester United is a global football brand with revenue upside from Champions League return and potential value unlocking.
Read the full thesis - September 2026
Cytokinetics is an early-commercial biotech whose lead drug has long-term growth potential in a large underserved market.
Read the full thesis - September 2026
Oscar Health is a tech-forward ACA insurer positioned to benefit from industry exits and long-term business improvements.
Read the full thesis - June 2026
FactSet Research Systems provides financial data and software and is pursuing AI-driven monetization opportunities.
Read the full thesis
Letter archive · 9
2026
- Sep 2026JAG Capital Management
- Sep 2026JAG Capital Management Quarterly Comments
- Sep 2026JAG Capital Management Large Cap Growth Strategy
- Sep 2026JAG Capital Management Small Mid Cap Growth Strategy
- Jun 2026JAG Capital Management Large Cap Growth Portfolio
- Jun 2026JAG Capital Management Small Mid Cap Growth Strategy
- Jun 2026JAG Capital Management Corporate Fixed Income
- Jun 2026JAG Capital Management Enhanced Core Fixed Income
- Jun 2026JAG Capital Management
Get JAG Capital Management’s next letter the day it lands
We track JAG Capital Management alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→